Y Intercept Hong Kong Ltd purchased a new stake in Bowhead Specialty Holdings Inc. (NYSE:BOW – Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 11,318 shares of the company’s stock, valued at approximately $317,000.
A number of other hedge funds have also recently bought and sold shares of BOW. American Century Companies Inc. acquired a new stake in shares of Bowhead Specialty in the 2nd quarter valued at approximately $23,148,000. Victory Capital Management Inc. raised its holdings in shares of Bowhead Specialty by 4.5% in the 3rd quarter. Victory Capital Management Inc. now owns 658,595 shares of the company’s stock valued at $18,447,000 after purchasing an additional 28,235 shares during the period. Wasatch Advisors LP lifted its stake in Bowhead Specialty by 16.9% in the 3rd quarter. Wasatch Advisors LP now owns 360,868 shares of the company’s stock valued at $10,108,000 after purchasing an additional 52,296 shares during the last quarter. Driehaus Capital Management LLC bought a new position in Bowhead Specialty during the second quarter worth about $7,866,000. Finally, Emerald Advisers LLC increased its position in Bowhead Specialty by 3.3% during the third quarter. Emerald Advisers LLC now owns 242,633 shares of the company’s stock worth $6,796,000 after buying an additional 7,683 shares during the last quarter.
Bowhead Specialty Price Performance
BOW opened at $35.65 on Wednesday. The stock has a fifty day moving average of $32.88 and a 200-day moving average of $29.41. Bowhead Specialty Holdings Inc. has a fifty-two week low of $22.14 and a fifty-two week high of $37.81.
Insiders Place Their Bets
In other Bowhead Specialty news, Director Family Mutual Insuran American sold 1,362,285 shares of the business’s stock in a transaction that occurred on Friday, October 25th. The shares were sold at an average price of $27.70, for a total transaction of $37,735,294.50. Following the completion of the transaction, the director now directly owns 4,700,761 shares in the company, valued at $130,211,079.70. The trade was a 22.47 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Analysts Set New Price Targets
A number of analysts have recently issued reports on BOW shares. Keefe, Bruyette & Woods raised their price objective on Bowhead Specialty from $35.00 to $36.00 and gave the company a “market perform” rating in a research report on Wednesday, December 4th. JMP Securities raised their price target on Bowhead Specialty from $32.00 to $33.00 and gave the company a “market outperform” rating in a report on Wednesday, November 6th. JPMorgan Chase & Co. upped their price objective on shares of Bowhead Specialty from $26.00 to $30.00 and gave the company a “neutral” rating in a report on Thursday, November 7th. Finally, Royal Bank of Canada raised their target price on shares of Bowhead Specialty from $32.00 to $35.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 6th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Bowhead Specialty has a consensus rating of “Hold” and an average price target of $32.00.
View Our Latest Research Report on BOW
About Bowhead Specialty
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Further Reading
- Five stocks we like better than Bowhead Specialty
- With Risk Tolerance, One Size Does Not Fit All
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- Pros And Cons Of Monthly Dividend Stocks
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.